Cathi Ahearn ā€” Vice President, Franchise Head for GI/GU Cancers, Cancer Immunothearpy & TECENTRIQ Cross-Indication at Roche | Comparably
Comparably
Roche Claimed Company
The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. read more
EMPLOYEE
PARTICIPANTS
671
TOTAL
RATINGS
4491
HR or Marketing? Claim Your Free Employer Account
Cathi Ahearn ā€” Vice President, Franchise Head for GI/GU Cancers, Cancer Immunothearpy & TECENTRIQ Cross-Indication at Roche

Cathi Ahearn ā€” Vice President, Franchise Head for GI/GU Cancers, Cancer Immunothearpy & TECENTRIQ Cross-Indication at Roche

Executive Bio

Cathi Ahearn serves as the Vice President, Franchise Head for GI/GU Cancers, Cancer Immunothearpy & TECENTRIQ Cross-Indication of Roche. Cathi started at Roche in January of 2018. Cathi currently resides in the San Francisco Bay Area.

Executive Team Culture Ratings from Roche Employees

TOP
15%
Roche's Executive Team scores in the Top 15%
of similar sized companies on Comparably
See Detailed Executive Team Ratings
Do you approve of the job your executive team is doing at your company?
82% Yes
82
Who ranks the Executive Team the highest?
Department - IT 97/100
Tenure - 5 to 10 Years 88/100
Experience - 6 to 10 Years 85/100
Who ranks the Executive Team the lowest?
Department - Sales 53/100
Ethnicity - Other 56/100
Ethnicity - Hispanic or Latino 58/100

Roche's Executive Team at a Glance

Based on 266 ratings, Roche's employees are very satisfied with their Executive Team and give them an ā€œA-ā€ or 75/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the IT department thinks more highly of the Executive Team relative to the Sales department.

Roche's Executive Team ranks in the Top 15% of other companies on Comparably that also have 10,000+ Employees.

×
Rate your company